STINGing leukemia stem cells through PSTK inhibition
In this issue of Blood, He et al provide compelling evidence that PSTK inhibition triggers ferroptotic cell death and links ferroptosis to cyclic GMP-AMP s
Related Articles
DLBclass: a probabilistic molecular classifier to guide clinical investigation and practice in diffuse large B-cell lymphoma
Key PointsWe developed a neural network–based probabilistic classifier, DLBclass, that assigns each DLBCL to its respective C1-C5 genetic subtype.DLBclass
Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotype
Key PointsAML-MP and MPAL are biologically distinct despite sharing features of MP.AML-MP and MPAL have differential responses to therapies.
Impact of Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis in Patients 70 years and Older: An Update from BMT CTN 1703
Key Points. PTCy based GVHD prophylaxis benefit extends to adults ≥ 70 years with improved GVHD control and improved immunosuppression-free survival.Overal
How I Treat Higher-Risk MDS
Myelodysplastic syndromes/neoplasms (MDS) are a widely heterogenous group of myeloid malignancies characterized by morphologic dysplasia, a defective hemat
How I treat higher-risk MDS
Not all patients with higher-risk myelodysplastic syndromes (MDSs) warrant or are suitable for allogeneic stem cell transplantation. Mina and Komrokji disc
Large clones of clonal hematopoiesis affect outcome in mantle cell lymphoma: results from the FIL MCL0208 clinical trial
Key PointsYoung untreated patients with MCL show 13% prevalence of M-CH at baseline.Large M-CH clones (variant allele frequency ≥ 10%) are associated with
Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotype
Key PointsAML-MP and MPAL are biologically distinct despite sharing features of MP.AML-MP and MPAL have differential responses to therapies.
Study Suggests Disparities in MM Outcomes Persist on a Global Scale | ASH Clinical News | American Society of Hematology
Khylia Marshall is a freelance journalist based in Tucson, Arizona. Previous studies have revealed disparities in the prevalence, management, and outcomes of multiple myeloma (MM)…
Targeting the DNA damage response through TBL1X in mantle cell lymphoma
Key PointsTBL1X plays a multifaceted role in promoting the proliferation and survival of MCL cells.Targeting TBL1X promotes destabilization of cyclin D1 an
Large clones of clonal hematopoiesis affect outcome in mantle cell lymphoma: results from the FIL MCL0208 clinical trial
Key PointsYoung untreated patients with MCL show 13% prevalence of M-CH at baseline.Large M-CH clones (variant allele frequency ≥ 10%) are associated with